Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2020 | Advances in the field of HSCT

Sergio Giralt • 7 Jul 2020
ESH AL 2020
General Leukemia Anti-thymocyte globulin

The success of hematopoietic stem cell transplantation (HSCT) has resulted from continuous advances in the field. Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the progress in the field since the first HSCT was performed fifty years ago. Dr Giralt reveals that many challenges remain, particularly in minimizing disease relapse and toxicities. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Sergio Giralt

How have the BMT CTN myeloma trials impacted clinical practice?
1:01
How have the BMT CTN myeloma trials impacted clinical practice?
Sergio Giralt • 2 Sep 2026
The recent expanded FDA approval of cilta-cel and ide-cel into earlier lines of myeloma treatment
0:36
The recent expanded FDA approval of cilta-cel and ide-cel into earlier lines of myeloma treatment
Sergio Giralt • 16 Apr 2024
Overcoming barriers to treating older patients with myeloma
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
The potentially curative role of CAR-T therapy in myeloma
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals